Hasil Pencarian (2)
biotech | CAS: 166663-25-8
Anidulafungin or Eraxis is an anti-fungal drug manufactured by Pfizer that gained approval by the Food and Drug Administration (FDA) in February 21, 2006; it was previously known as LY303366. There is preliminary evidence that it has a similar safety profile …
Kategori:
Amino Acids, Peptides, and ProteinsAnti-Infective AgentsAntifungal Agents
+6
Target Protein:
1,3-beta-glucan synthase component FKS11,3-beta-glucan synthase component GSC2
Waktu Paruh40-50 hours
Vol. Distribusi* 30 to 50 L
Klirens* 1 L/h
Genetik
-
small molecule | CAS: 1207753-03-4
Ibrexafungerp, also known as SCY-078 or MK-3118, is a novel enfumafungin derivative oral triterpene antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known as a vaginal yeast infection.[A235384,L34349] It was developed out of a nee…
Kategori:
Anti-Infective AgentsAntifungal AgentsAntiinfectives for Systemic Use
+17
Target Protein:
1,3-beta-glucan synthase component GSC2GTP-binding protein RHO1
Waktu ParuhThe elimination hal…
Vol. DistribusiThe volume of distr…
KlirensClearance values of…
Genetik
-